Cargando…
Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance
S100P belongs to the S100 family of calcium-binding proteins regulating diverse cellular processes. Certain S100 family members (S100A4 and S100B) are associated with cancer and used as biomarkers of metastatic phenotype. Also S100P is abnormally expressed in tumors and implicated in migration-invas...
Autores principales: | Gibadulinova, Adriana, Pastorek, Michal, Filipcik, Pavel, Radvak, Peter, Csaderova, Lucia, Vojtesek, Borivoj, Pastorekova, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008377/ https://www.ncbi.nlm.nih.gov/pubmed/26967060 http://dx.doi.org/10.18632/oncotarget.7999 |
Ejemplares similares
-
The calcium-binding protein S100P in normal and malignant human tissues
por: Parkkila, Seppo, et al.
Publicado: (2008) -
Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment
por: Hrstka, Roman, et al.
Publicado: (2009) -
Hypoxia induces cancer-associated cAMP/PKA signalling through HIF-mediated transcriptional control of adenylyl cyclases VI and VII
por: Simko, Veronika, et al.
Publicado: (2017) -
Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses
por: Obacz, Joanna, et al.
Publicado: (2013) -
Switching p53-dependent growth arrest to apoptosis via the inhibition of DNA damage-activated kinases
por: Hublarova, Pavla, et al.
Publicado: (2010)